Antiretroviral HIV treatment and care for injecting drug users: an evidence-based overview.
AIDS-related mortality and the rate of progression to AIDS have dramatically decreased since the advent of highly active antiretroviral treatment (HAART). The overall benefit from antiretroviral HIV treatment has, however, been lesser in HIV-infected injecting drug users (IDUs) than in other patient groups (e.g. men who have sex with men). Poorer outcomes in HIV-infected IDUs are related to a variety of factors, including increased rates of non-HIV-related deaths, hepatitis C, delayed access to effective treatment, lower adherence to care and treatment regimens, continuation of illicit drug use, depression and negative life events. The available evidence strongly suggests the need for the large-scale implementation of comprehensive treatment and care strategies for IDUs that include both treatment of drug dependence and HAART.
Lert
France
F
INSERM U687, Saint-Maurice, France.
Kazatchkine
Michel D
MD
D023241:Antiretroviral Therapy, Highly Active; D019317:Evidence-Based Medicine; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D006297:Health Services Accessibility / Q000458:organization & administration*; D006801:Humans; D016320:Substance Abuse Treatment Centers / Q000458:organization & administration*; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D016312:Treatment Refusal
AIDS. 2006 Jan 2;20(1):67-71
16327321
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S89-95
16265622
Am J Epidemiol. 2006 Mar 1;163(5):412-20
16394200
AIDS. 2006 Jan 9;20(2):289-91
16511426
AIDS. 2006 Apr 4;20(6):901-6
16549975
J Acquir Immune Defic Syndr. 2006 Apr 15;41(5):563-72
16652030
AIDS. 2006 May 12;20(8):1171-9
16691069
Drug Alcohol Depend. 2006 Sep 15;84(2):188-94
16542797
Lancet. 2006 Aug 5;368(9534):451-8
16890831
AIDS Res Hum Retroviruses. 2006 Aug;22(8):715-23
16910826
Addiction. 2006 Sep;101(9):1246-53
16911723
AIDS. 2007 Jan;21 Suppl 1:S5-12
17159588
Euro Surveill. 2006;11(11):E061123.2
17213556
AIDS. 2000 Jan 28;14(2):151-5
10708285
AIDS. 1999;13 Suppl A:S259-69
10885783
JAMA. 2002 Jul 10;288(2):199-206
12095384
Lancet. 2002 Jul 13;360(9327):119-29
12126821
AIDS. 2002 Sep 6;16(13):F25-31
12218407
HIV Med. 2003 Jan;4(1):33-7
12534957
J Urban Health. 2003 Jun;80(2):274-87
12791803
Lancet. 2003 Oct 18;362(9392):1267-74
14575971
J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):46-51
14707791
AIDS. 2004 Sep 3;18(13):1835-43
15316345
J Acquir Immune Defic Syndr. 2004 Nov 1;37(3):1423-30
15483472
AIDS. 1997 Apr;11(5):621-31
9108944
AIDS. 1997 Nov 15;11(14):1747-56
9386810
AIDS. 1998 Aug 20;12(12):1537-44
9727576
J Epidemiol Community Health. 1999 Jan;53(1):4-8
10326045
AIDS. 2004 Oct 21;18(15):2039-45
15577625
AIDS. 2004 Nov 19;18(17):2295-303
15577542
AIDS. 2004 Nov 19;18(17):2333-7
15577550
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):74-81
15608529
Am J Epidemiol. 2005 Feb 1;161(3):271-9
15671259
Antivir Ther. 2005;10(1):53-61
15751763
Arch Intern Med. 2005 Mar 28;165(6):618-23
15795336
AIDS. 2005 May 20;19(8):837-9
15867502
J Hepatol. 2005 Jun;42(6):799-805
15973779
Drug Alcohol Depend. 2005 Aug 1;79(2):137-43
16002023
Lancet. 2005 Jul 30-Aug 5;366(9483):378-84
16054937
Eur J Epidemiol. 2005;20(9):795-804
16170664
AIDS. 2006 Feb 14;20(3):445-50
16439879